MCOLN1 and ovarian carcinoma: In this study, we conducted a metabolomic analysis to identify specific metabolites altered in response to an inhibitor of the lysosomal calcium channel TRPML1, aiming to enhance the sensitivity of chemoresistant ovarian cancer cells to cisplatin.